{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:31:00Z","timestamp":1761561060496},"reference-count":37,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2006,5,31]],"date-time":"2006-05-31T00:00:00Z","timestamp":1149033600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arthritis &amp; Rheumatism"],"published-print":{"date-parts":[[2006,6,15]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Objective<\/jats:title><jats:p>To determine the effect of limited cutaneous systemic sclerosis (lcSSc) on patients' health status, and to identify the contributions to health status of different manifestations of lcSSc.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>The Short Form 36 questionnaire was completed by 213 patients with lcSSc or Raynaud's syndrome and an antinuclear antibody typical of lcSSc as part of the baseline visit of the Quinapril in Scleroderma trial. Results were analyzed after correcting for age and sex using the Welsh Health Survey. Patients' results were related to their clinical characteristics.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The mean physical component score (PCS) was 44.0 (95% confidence interval [95% CI] 42.5, 45.5), which was lower than the population norm of 50, and the median mental component score (MCS) was 52.2 (95% CI 48.5, 54.3). Raynaud's disease visual analog scale (VAS) scores, lung function, the number of organ systems affected, and skin score were significantly correlated with PCS. The total score (TDS) of an SSc severity scale showed the highest correlation. The effect of lcSSc on PCS was worse in younger patients. Multiple regression including age demonstrated that Raynaud's disease severity could predict a reduction in PCS beyond that predicted by TDS. Raynaud's disease severity and duration of lcSSc were linked to low MCS. Arthritis reduced PCS and esophageal involvement reduced PCS and MCS.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Physical health status of patients with lcSSc was reduced, with 30% of the variation predicted by TDS, age, and severity of Raynaud's disease VAS. Mental health status was not reduced in this population.<\/jats:p><\/jats:sec>","DOI":"10.1002\/art.21999","type":"journal-article","created":{"date-parts":[[2006,6,1]],"date-time":"2006-06-01T00:28:46Z","timestamp":1149121726000},"page":"473-479","source":"Crossref","is-referenced-by-count":25,"title":["Influence of clinical features on the health status of patients with limited cutaneous systemic sclerosis"],"prefix":"10.1002","volume":"55","author":[{"given":"Angela E.","family":"Gliddon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline J.","family":"Dor\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter J.","family":"Maddison","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"QUINS TRIAL STUDY GROUP","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2006,5,31]]},"reference":[{"key":"e_1_2_5_2_2","first-page":"202","article-title":"Scleroderma (systemic sclerosis): classification, subsets and pathogenesis","volume":"15","author":"LeRoy EC","year":"1988","journal-title":"J Rheumatol"},{"volume-title":"SF36 Health Survey: manual and interpretation guide","year":"2000","author":"Ware JE","key":"e_1_2_5_3_2"},{"key":"e_1_2_5_4_2","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/41.9.965"},{"key":"e_1_2_5_5_2","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/31.7.457"},{"key":"e_1_2_5_6_2","first-page":"2159","article-title":"A disease severity scale for systemic sclerosis: development and testing","volume":"26","author":"Medsger TA","year":"1999","journal-title":"J Rheumatol"},{"volume-title":"SF\u201036 physical and mental health summary scales: a manual for users of version 1","year":"2001","author":"Ware JE","key":"e_1_2_5_7_2"},{"volume-title":"Welsh Health Survey","year":"1998","author":"National Assembly for Wales","key":"e_1_2_5_8_2"},{"key":"e_1_2_5_9_2","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(199912)42:12<2660::AID-ANR23>3.0.CO;2-N"},{"key":"e_1_2_5_10_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002281-199711000-00014"},{"key":"e_1_2_5_11_2","doi-asserted-by":"publisher","DOI":"10.1177\/0148607189013002147"},{"key":"e_1_2_5_12_2","doi-asserted-by":"publisher","DOI":"10.1002\/micr.1013"},{"key":"e_1_2_5_13_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0781.2000.160505.x"},{"key":"e_1_2_5_14_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.1790080312"},{"key":"e_1_2_5_15_2","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keh070"},{"key":"e_1_2_5_16_2","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/38.6.535"},{"key":"e_1_2_5_17_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780401110"},{"key":"e_1_2_5_18_2","first-page":"129","article-title":"Explorative study on quality of life in patients with progressive\u2010systemic scleroderma","volume":"25","author":"Oelzner S","year":"1999","journal-title":"Aktuelle Derm"},{"key":"e_1_2_5_19_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.1998.02460.x"},{"key":"e_1_2_5_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0304-3959(01)00409-2"},{"key":"e_1_2_5_21_2","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(199910)42:10<2220::AID-ANR26>3.0.CO;2-5"},{"key":"e_1_2_5_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(99)00052-2"},{"key":"e_1_2_5_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(99)70246-X"},{"key":"e_1_2_5_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0248-8663(03)00268-6"},{"key":"e_1_2_5_25_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.20389"},{"key":"e_1_2_5_26_2","first-page":"122","article-title":"Evaluation of quality of life in patients with systemic sclerosis by administering the SF\u201036 questionnaire","volume":"54","author":"Cossutta R","year":"2002","journal-title":"Reumatismo"},{"key":"e_1_2_5_27_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2168.2002.02119.x"},{"key":"e_1_2_5_28_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.20787"},{"key":"e_1_2_5_29_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-004-0970-z"},{"volume-title":"Measuring health: a review of quality of life measurement scales","year":"1991","author":"Bowling A","key":"e_1_2_5_30_2"},{"volume-title":"Health Survey for England in 1996","year":"1998","key":"e_1_2_5_31_2"},{"key":"e_1_2_5_32_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.305.6846.160"},{"key":"e_1_2_5_33_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.306.6890.1437"},{"key":"e_1_2_5_34_2","doi-asserted-by":"publisher","DOI":"10.1080\/03009740410006060"},{"key":"e_1_2_5_35_2","first-page":"51","article-title":"Correlates of depression, including overall and gastrointestinal functional status, among patients with systemic sclerosis","volume":"32","author":"Nietert PJ","year":"2005","journal-title":"J Rheumatol"},{"key":"e_1_2_5_36_2","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/37.4.425"},{"key":"e_1_2_5_37_2","first-page":"231","article-title":"Health\u2010related quality of life in early rheumatoid arthritis: impact of disease and treatment response","volume":"8","author":"Kosinski M","year":"2002","journal-title":"Am J Manag Care"},{"key":"e_1_2_5_38_2","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keh580"}],"container-title":["Arthritis Care &amp; Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fart.21999","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/art.21999","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,17]],"date-time":"2023-10-17T07:30:42Z","timestamp":1697527842000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/art.21999"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,5,31]]},"references-count":37,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2006,6,15]]}},"alternative-id":["10.1002\/art.21999"],"URL":"https:\/\/doi.org\/10.1002\/art.21999","archive":["Portico"],"relation":{},"ISSN":["0893-7524","1529-0123"],"issn-type":[{"type":"print","value":"0893-7524"},{"type":"electronic","value":"1529-0123"}],"subject":[],"published":{"date-parts":[[2006,5,31]]}}}